Pharma

Supreme Court Set to Deliver Landmark Verdict on Purdue Pharma Bankruptcy Amid Opioid Epidemic

by

Washington, D.C. – A pivotal decision is expected from the U.S. Supreme Court regarding the bankruptcy case of Purdue Pharma LP, as the nation continues grappling with an opioid crisis that has claimed over 750,000 lives to date. This ruling could herald a significant development in addressing the ramifications of one of the deadliest health emergencies in American history. Purdue Pharma, the maker of OxyContin, has been at the epicenter of lawsuits and public outcry, with numerous claims that the company aggressively marketed its highly addictive painkiller without proper warnings of its potential for abuse. … Read more

Amid Purdue Pharma Legal Battles, Calls for Comprehensive Mass Tort Legislation Intensify

by

Washington – The recent Purdue Pharma ruling has reignited discussions on the urgent need for reform in the mass tort litigation system across the United States, spotlighting deep-seated issues impacting both plaintiffs and defendants. While specific cases, such as the opioid crisis lawsuits, bring to light individual corporate misconduct, they also underscore a wider systemic challenge that demands attention irrespective of single case outcomes. Mass tort cases involve lawsuits where numerous plaintiffs are directed against one or a few corporate defendants. Typically, these cases arise from claims where parties allege harm from products such as … Read more

Supreme Court Ruling Redefines Chapter 11 Terrain in Landmark Purdue Pharma Case

by

Washington, D.C. – A recent Supreme Court decision has significantly reshaped the landscape of Chapter 11 bankruptcy, particularly spotlighting the case involving Purdue Pharma. This ruling may set a new precedent for how large corporations can handle bankruptcy claims, especially with the added complexity of widespread public health implications. Chapter 11 bankruptcy, often used by corporations to reorganize and continue operation while managing debt, has been thrust into the spotlight amid the opioid crisis. Purdue Pharma, known for manufacturing the powerful painkiller OxyContin, filed for bankruptcy in 2019 as it faced thousands of lawsuits alleging … Read more

Amid Purdue Pharma Controversy, Calls for Overhaul in Mass Tort Laws Gain Momentum

by

Washington, D.C. — As legal battles loom large over corporate America, with the opioid crisis and Purdue Pharma at the forefront, the clamor for significant mass tort reform grows louder. These complex legal confrontations, involving multiple plaintiffs and extensive allegations of harm caused by companies, underscore the urgent need for a revamp of the system that many argue is no longer fit for its intended purpose. Mass tort cases are quintessentially large-scale, involving numerous individuals against one or several corporate entities. The Purdue Pharma case, tied to the opioid epidemic, is a prime example. It … Read more